| |
| |
|
| Insider
Information: |
Poirson Allen |
| Relationship: |
|
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
51,055 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$321,647 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
51,055 |
|
|
| Total
Value |
$321,647 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytek Biosciences, Inc. |
CTKB |
|
2024-03-11 |
51,055 |
2021-07-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTKB |
Cytek Biosciences, Inc. |
SVP BUS. AND CORP. DEV. |
• – – |
2024-03-11 |
4 |
D |
$7.22 |
$9,393 |
D/D |
(1,301) |
51,055 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP BUS. AND CORP. DEV. |
• – – |
2024-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,338 |
52,356 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP BUS. AND CORP. DEV. |
• – – |
2024-02-20 |
4 |
D |
$8.38 |
$2,581 |
D/D |
(308) |
49,018 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP BUS. AND CORP. DEV. |
• – – |
2024-02-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
790 |
49,326 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Bus. and Corp. Dev. |
• – – |
2023-11-18 |
4 |
D |
$5.98 |
$7,672 |
D/D |
(1,283) |
48,536 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Bus. and Corp. Dev. |
• – – |
2023-11-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,293 |
49,511 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Bus. and Corp. Dev. |
• – – |
2023-08-18 |
4 |
D |
$8.46 |
$10,854 |
D/D |
(1,283) |
46,526 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Bus. and Corp. Dev. |
• – – |
2023-08-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,293 |
47,501 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Bus. and Corp. Dev. |
• – – |
2023-05-18 |
4 |
D |
$6.69 |
$6,416 |
D/D |
(959) |
44,208 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Bus. and Corp. Dev. |
• – – |
2023-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,459 |
44,859 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Bus. and Corp. Dev. |
• – – |
2023-02-21 |
4 |
D |
$10.97 |
$3,379 |
D/D |
(308) |
42,708 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Bus. and Corp. Dev. |
• – – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
790 |
43,016 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Bus. and Corp. Dev. |
• – – |
2022-11-18 |
4 |
D |
$14.75 |
$4,543 |
D/D |
(308) |
41,989 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Bus. and Corp. Dev. |
• – – |
2022-11-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
790 |
42,297 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Marketing and Corp. Dev. |
• – – |
2022-08-18 |
4 |
D |
$14.06 |
$4,330 |
D/D |
(308) |
41,507 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Marketing and Corp. Dev. |
• – – |
2022-08-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
790 |
41,815 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Marketing and Corp. Dev. |
• – – |
2022-05-18 |
4 |
D |
$9.65 |
$3,966 |
D/D |
(411) |
41,025 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Marketing and Corp. Dev. |
• – – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,053 |
41,436 |
0 |
- |
|
| CTKB |
Cytek Biosciences, Inc. |
SVP Marketing and Corp. Dev. |
• – – |
2021-07-22 |
4 |
B |
$17.00 |
$25,500 |
D/D |
1,500 |
40,383 |
2.74 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
